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Benzaldehydes with electron-donating substituents react smoothly with a nonstabilized azomethine
ylide derived from sarcosine and formaldehyde to form 5-aryloxazolidines as intermediates, which
undergo rearrangement into 2-methyl-1,2,3,4-tetrahydroisoquinolin-4-ols in high yields by simple
heating with hydrochloric acid. This one-pot synthesis of tetrahydroisoquinolines can be considered as
a formal [3+3] cycloaddition of the azomethine ylide to the aromatic aldehyde.
 2013 Elsevier Ltd. All rights reserved.N
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OHThe chemistry of 4-substituted-l,2,3,4-tetrahydroisoquinolines
has attracted considerable attention from the synthetic commu-
nity due to their distribution in nature and their wide spectrum
of biological activity.1 Examples of such tetrahydroisoquinolin-4-
ols include longimammamine (1) and 4,6-dihydroxy-2-methyl-
1,2,3,4-tetrahydroisoquinoline (2) isolated from Dolichothele
longimamma and Theobroma cacao, respectively (Fig. 1).2
Synthetic analogs of tetrahydroisoquinolinols 1 and 2 have been
proposed as potential antihypertensive drugs.3a,b Recently, a Lewis
acid catalyzed arylation of tetrahydroisoquinolin-4-ols with thio-
anisole was reported.3c This reaction opens a new approach to
the synthesis of 4-aryltetrahydroisoquinolines, which can function
as serotonin–norepinephrine–dopamine reuptake inhibitors.3d–f
Taking into account other methods of functionalization, the tetra-
hydroisoquinolin-4-ol core is a valuable building block for the con-
struction of a wide range of isoquinoline derivatives.4a–i
Due to the important applications of this class of compounds,
their synthesis has been extensively studied.4 There are two classi-
cal methods for the preparation of tetrahydroisoquinolin-4-ols.
The ﬁrst is the Pictet–Spengler cyclization of hydroxyphenethyl-
amines 3, which are not easily accessible,4a–d and the second is
the Pomeranz–Fritsch–Bobbitt acid-catalyzed cyclization of N-ben-
zyl-N-methylaminoacetaldehyde diethyl acetals 4.4d–l Both reac-
tions involve multistep procedures and require electron-donating
substituents on the aromatic ring of the substrate. The secondll rights reserved.method is often more efﬁcient due to the fewer number of steps in-
volved from the starting benzaldehydes (Scheme 1).
On the other hand, it is well-known that nonstabilized azome-
thine ylides generated from sarcosine (5) and formaldehyde,5a,b
or silyl precursor 6 in the presence of triﬂuoroacetic acid5c,d add
to the carbonyl group of benzaldehydes and benzophenone5e to
form 5-aryloxazolidines 7. Their methylene group, the former azo-
methine ylide cationic center, still has electrophilic character after
the cycloaddition step due to the presence of two geminal acceptor
atoms and the easy cleavage of the C–O acetal bond. It would be
reasonable to assume the possibility of the Pictet–Spengler intra-
molecular recyclization with the formation of the tetrahydroiso-
quinoline core 8 (Scheme 2). In general, these two successive
reactions can be considered as a formal [3+3] cycloaddition of
the nonstabilized azomethine ylide with the aromatic aldehyde
or ketone, followed by proton migration. In this context, and in
connection with our interest in the development of azomethine
ylide chemistry,6 a method based on a 1,3-dipolar cycloaddition1 2
Figure 1. Examples of natural alkaloids containing a tetrahydroisoquinolin-4-ol
framework.
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Scheme 3. One-pot synthesis of the tetrahydroisoquinolin-4-ol 8a.
Table 1
Yields and melting points of the products 8a–f
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Scheme 1. The classical syntheses of tetrahydroisoquinolin-4-ols.
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oxazolidine 7 into tetrahydroisoquinoline system 8, in a one-pot
procedure, attracted our attention. To the best of our knowledge,
no such transformation has been reported.
To test the feasibility of the envisioned idea, the reaction of m-
anisaldehyde with the nonstabilized azomethine ylide derived
from sarcosine and formaldehyde was ﬁrst investigated. We found
that reﬂuxingm-anisaldehyde, sarcosine, and paraformaldehyde in
benzene for 6 h with azeotropic removal of water resulted in the
formation of previously unknown 5-(3-methoxyphenyl)-3-methyl-
oxazolidine (7a) (yield 97%). The crude product was sufﬁciently
pure according to the 1H NMR spectrum and only a trace (4%) of
the starting aldehyde was observed. To our delight, simple heating
of oxazolidine 7a in 6 M HCl at 60 C resulted in full recyclization
into the desired product, 6-methoxy-2-methyl-1,2,3,4-tetrahydro-
isoquinolin-4-ol (8a).7,8 Subsequent basiﬁcation of the reaction
mixture and extraction with ether gave the rearranged product
8a as a white solid in 89% isolated yield, based on the starting
m-anisaldehyde (Scheme 3). Apparently, this intramolecular
reaction was mediated by HCl, where protonation of the oxygenN
Bn
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Scheme 2. Cycloaddition of aromatic aldehydes and ketones with azomethine
ylides.
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63 79–81e
a This compound was mentioned in Ref. 4c without any data.
b Mp 127–128 C (Ref. 4e,f), mp 124–126 C (Ref. 4g).
c Mp of the hydrochloride 189–191 C (Ref. 4b).
d This compound was reported in Ref. 4k without any data, only the mp 106–
108 C was described.
e This compound was reported in Ref. 10a without any data, only the mp 145 C
of the maleate was given.atom facilitates breakdown of the oxazolidine ring to give cationic
intermediate A, which acts as an internal electrophile.
With optimal conditions for the one-pot synthesis of tetra-
hydroisoquinolinol 8a in hand, reactions with other aromatic alde-
hydes bearing electron-donating substituents were investigated.
As can be seen from Table 1, the reactions of veratraldehyde,
3,4,5-trimethoxybenzaldehyde,9 O-benzyl vanillin, and 3,4-meth-
ylendioxybenzaldehyde proceeded smoothly to afford the desired
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been reported earlier.4e–g Using this approach we were also able
to obtain 5-methyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-7-ol
(8f) from thiophene-2-carbaldehyde in 63% yield under the same
conditions, which may be of interest as a therapeutically valuable
compound.10 However, all our attempts to rearrange the oxazoli-
dines obtained from benzaldehyde and anisaldehyde failed (the
former at a higher temperature led to partial hydrolysis of the oxa-
zolidine ring with extrusion of formaldehyde, while the latter gave
an insoluble dark gum). The lack of reactivity in these cases was
apparently due to the low nucleophilicity of the benzene ring.
These results clearly show that at least one electron-donating
meta-substituent must be present on the aromatic aldehyde for
the successful electrophilic aryloxazolidine–tetrahydroisoquino-
line rearrangement. The structures of products 8a–f were
characterized by IR, 1H, and 13C NMR spectral data as well as by
elemental analysis.
Comparing with the Pictet–Spengler cyclization of the corre-
sponding hydroxyphenethylamines, this reaction proceeds with
high regioselectivity. No 8-methoxy regioisomer was observed.2a
Also it should be noted that the preparation of N-benzyl-N-
methylaminoacetaldehyde diethyl acetal from m-anisaldehyde
followed by Pomeranz–Fritsch–Bobbitt cyclization leads to
7-methoxytetrahydroisoquinoline, while the reaction described
here gives 6-methoxy isomer and is a good addition to the classical
method. Moreover, unlike both previously known approaches for
the synthesis of tetrahydroisoquinolines from aromatic aldehydes,
this process does not require any reducing agent or chromato-
graphic puriﬁcation of the intermediate liquid oxazolidines,
and thereby greatly facilitates the preparation of the target
tetrahydroisoquinolinols.
In conclusion, we have developed a simple and convenient one-
pot method for the synthesis of 2-methyl-1,2,3,4-tetrahydroiso-
quinolin-4-ols from aromatic aldehydes bearing electron-donating
substituents and an azomethine ylide derived from sarcosine and
formaldehyde, via a novel aryloxazolidine–tetrahydroisoquinoline
rearrangement. Compared with the previously known procedures,
our method shows several advantages, the main of which are sim-
plicity, efﬁciency, and easy availability of the starting materials.
Further application of this reaction for the construction of substi-
tuted tetrahydroisoquinolines and their heteroanalogs is underway
in our laboratory and will be reported in due course.
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